Evidence map›Paper›PMID 36358245›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Ag-Modified ZnO for Degradation of Oxytetracycline Antibiotic and Reactive Red Azo Dye.

Khemika Wannakan, Kamonpan Khansamrit, Teeradech Senasu, Tammanoon Chankhanittha, Suwat Nanan

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Khemika WannakanMaterials Chemistry Research Center, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Kamonpan KhansamritMaterials Chemistry Research Center, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Teeradech SenasuMaterials Chemistry Research Center, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Tammanoon ChankhanitthaMaterials Chemistry Research Center, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.
Suwat NananMaterials Chemistry Research Center, Department of Chemistry and Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Khon Kaen University, Khon Kaen 40002, Thailand.ORCID 0000-0002-8737-689X
Khon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is known that low electron-hole separation efficiency is the major disadvantage influencing low photoactivity of the UV-active ZnO photocatalyst. To solve this drawback, the excellent fabrication technique has been used to disperse silver metal on ZnO surface. In this study, an addition of silver content up to 15 wt% was carried out. The 5Ag-ZnO sample, comprising 5 wt% of silver metal, displayed a hexagonal wurtzite structure, and a band gap of 3.00 eV, with high sunlight-active photocatalytic performance of 99-100% and low photo-corrosion problem. The complete degradation of oxytetracycline (OTC) antibiotic and reactive red dye 141 (RR141) dye under natural sunlight was achieved. The highest rate constant of 0.061 min

Indexed as

Ag-decorated ZnOoxytetracyclinephotodegradationreactive red dyesunlight

Identifiers

PMID36358245
PMCPMC9686815
OpenAlexW4308775068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.